Thursday, Sep 21, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Zydus Cadila Gets Usfda Nod To Market Hiv Infection Treatment Tablets

Zydus Cadila gets USFDA nod to market HIV infection treatment tablets

The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad.

By PTI
Published Date - 02:51 PM, Fri - 2 July 21
Zydus Cadila gets USFDA nod to market HIV infection treatment tablets
whatsapp facebook twitter telegram

New Delhi: Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market generic Emtricitabine and Tenofovir Disoproxil Fumarate tablets used for treatment of HIV infection.

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 100 mg/150 mg, 133 mg/200 mg and 167 mg/250 mg, Zydus Cadila said in a statement.

The drug will be manufactured at the group’s formulation manufacturing facility at SEZ, Ahmedabad, it added.

The drug is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in one’s body so that the immune system can work better, Zydus Cadila said.

The group now has 319 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of its filing process, it added.

Shares of Cadila Healthcare, the listed entity of Zydus group were trading at Rs 639.95 per scrip on BSE, up 0.18 per cent from its previous close.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .


Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • Emtricitabine
  • HIV
  • HIV infection
  • HIV infection treatment

Related News

  • Aurobindo’s Andhra plant gets 1 observation from USFDA post inspection

    Aurobindo’s Andhra plant gets 1 observation from USFDA post inspection

  • USFDA issues warning letter to Intas Pharma for Sanand plant

    USFDA issues warning letter to Intas Pharma for Sanand plant

  • Study finds new HIV drug formulation potentially enhancing treatment outcomes for children worldwide

    Study finds new HIV drug formulation potentially enhancing treatment outcomes for children worldwide

  • How hepatitis is linked with diabetes, HIV

    How hepatitis is linked with diabetes, HIV

  • Person suffering from HIV cannot be denied employment or promotion: Allahabad HC

    Person suffering from HIV cannot be denied employment or promotion: Allahabad HC

  • INVEX Health to launch India’s first oral HIV self-test soon

    INVEX Health to launch India’s first oral HIV self-test soon

Latest News

  • Four-day annual Ladakh festival begins in Leh

    3 mins ago
  • Hyderabad She teams nab 55 persons for stalking, harassing women at Khairatabad Ganesh pandal

    4 mins ago
  • Glenmark Pharma to sell 75% stake in life sciences unit to Nirma for Rs 5,651 cr

    3 mins ago
  • Devi Prasad’s poetry collection ‘Blissful Rambles’ launched

    8 mins ago
  • Why Indian batters don’t bowl? Blame it on five-fielder rule: Dravid

    10 mins ago
  • Mumbai: Two persons get 10 years in jail in 2015 fake Indian currency note case

    14 mins ago
  • Former Ramayampet MLA RS Vasu Reddy passes away

    20 mins ago
  • Queen of hearts: Sara Ali Khan wishes Kareena Kapoor Khan on her birthday

    24 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam